Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Peripheral myelin protein 22
(
PMP22
) is a dose-sensitive, disease-associated protein primarily expressed in myelinating Schwann cells. Either reduction or overproduction of
PMP22
can result in hereditary neuropathy, suggesting a requirement for correct protein expression for peripheral nerve biology.
PMP22
is post-transcriptionally regulated and the 3'untranslated region (3'UTR) of the gene exerts a negative effect on translation. MicroRNAs (miRNAs) are small regulatory molecules that function at a post-transcriptional level by targeting the 3'UTR in a reverse complementary manner. We used cultured Schwann cells to demonstrate that alterations in the miRNA biogenesis pathway affect
PMP22
levels, and endogenous
PMP22
is subjected to miRNA regulation. GW-body formation, the proposed cytoplasmic site for miRNA-mediated repression, and Dicer expression, an
RNase III
family ribonuclease involved in miRNA biogenesis, are co-regulated with the differentiation state of Schwann cells. Furthermore, the levels of Dicer inversely correlate with
PMP22
, while the inhibition of Dicer leads to elevated
PMP22
. Microarray analysis of actively proliferating and differentiated Schwann cells, in conjunction with bioinformatics programs, identified several candidate
PMP22
-targeting miRNAs. Here we demonstrate that miR-29a binds and inhibits
PMP22
reporter expression through a specific miRNA seed binding region. Over-expression of miR-29a enhances the association of
PMP22
RNA with Argonaute 2, a protein involved in miRNA function, and reduces the steady-state levels of
PMP22
. In contrast, inhibition of endogenous miR-29a relieves the miRNA-mediated repression of
PMP22
. Correlation analyses of miR-29 and
PMP22
in sciatic nerves reveal an inverse relationship, both developmentally and in post-crush injury. These results identify
PMP22
as a target of miRNAs and suggest that myelin gene expression by Schwann cells is regulated by miRNAs.
...
PMID:Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. 1917 Jan 79